SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-021756
Filing Date
2022-06-09
Accepted
2022-06-09 20:02:52
Documents
1
Period of Report
2022-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6011
  Complete submission text file 0000899243-22-021756.txt   7541
Mailing Address 555 SKOKIE BOULEVARD, SUITE 340 NORTHBROOK IL 60062
Business Address 555 SKOKIE BOULEVARD, SUITE 340 NORTHBROOK IL 60062 (847) 562-4300
Clarus Therapeutics Holdings, Inc. (Issuer) CIK: 0001817944 (see all company filings)

IRS No.: 851231852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CLARUS THERAPEUTICS HOLDINGS, INC. 555 SKOKIE BLVD, SUITE 340 NORTHBROOK IL 60662
Business Address
Amory John Kenneth (Reporting) CIK: 0001876555 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39802 | Film No.: 221007368